Severely depressed patient treated via a personalized neural biomarker.
Personalized medicine is the applied treatment or medication that is based on information about a patient’s genetics, lifestyle, and environment. A new study published in Nature Medicine shows how the combination of precision-medicine and deep brain stimulation (DBS) successfully treated a patient with severe treatment-resistant depression.
Led by Andrew Krystal, PhD, professor of psychiatry and member of the University of California San Francisco (UCSF) Weill Institute for Neurosciences, the study opens the possibility of using a precision-medicine approach combined with deep brain stimulations for the treatment of psychiatric disorders.
Researchers discovered a neural biomarker by finding the pattern of brain activity associated with the onset of symptoms and used that data to personalize a DBS device to activate when the pattern is spotted. Specifically, the device gave a 1mA electrical stimulation for six seconds when it detected the neural biomarker.
Continue reading… “First Personalized Deep Brain Stimulation Treats Depression”
